Insider Purchase: DaVita Director Acquires 369 Shares (Form 4)

Rhea-AI Filing Summary

DaVita Inc. director Barbara J. Desoer, through an attorney-in-fact, reported acquiring 369 shares of DaVita common stock on 08/15/2025 at no cash price indicated on the form and holds 369 shares directly following the transaction. The filing shows she also has indirect beneficial ownership of 12,659 shares through the Marc J. Desoer and Barbara J. Desoer 1998 Trust dated September 7, 1998. The Form 4 was signed by Stephanie N. Berberich as attorney-in-fact on 08/19/2025.

Insights

Securities Analyst

TL;DR: Small insider acquisition by a director; immaterial to company valuation but shows insider buying.

The reported purchase of 369 shares by Director Barbara J. Desoer is a routine insider transaction disclosed on Form 4. Given the reported size (369 shares) relative to a public company of DaVita's scale, this trade is unlikely to be material to the companys capitalization or operations. The filing also confirms existing indirect ownership of 12,659 shares via a family trust, clarifying the reporting persons aggregate holdings. No derivative transactions or additional compensatory awards are reported.

Corporate Governance Expert

TL;DR: Governance disclosure is complete for the transaction; filing follows Section 16 reporting protocols.

The Form 4 discloses the directors purchase and the trust-based indirect ownership, meeting Section 16(a) requirements. The filing was executed by an attorney-in-fact and includes the trustee-related indirect ownership attribution. There are no amendments, derivative instruments, or other unusual features reported that would raise governance concerns.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

DESOER BARBARA J

(Last) (First) (Middle)

C/O DAVITA INC.

2000 16TH STREET

(Street)

DENVER CO 80202

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
DAVITA INC. [ DVA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/15/2025		A		369	A	$0	369	D
Common Stock								12,659	I	Marc J. Desoer and Barbara J. Desoer 1998 Trust dated September 7, 1998

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	/s/ Stephanie N. Berberich, Attorney-in-Fact	08/19/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Barbara J. Desoer report on the DaVita (DVA) Form 4?

She reported acquiring 369 shares of DaVita common stock on 08/15/2025 and holds 369 shares directly after the transaction.

Does the Form 4 show any derivative or option transactions for DVA?

No. Table II (derivative securities) contains no reported transactions or holdings.

How many shares does Barbara J. Desoer indirectly own in DVA?

12,659 shares are reported as indirectly beneficially owned through the Marc J. Desoer and Barbara J. Desoer 1998 Trust dated September 7, 1998.

When was the Form 4 signed and by whom?

Signed by Stephanie N. Berberich, Attorney-in-Fact, on 08/19/2025.

Was a purchase price disclosed for the 369 shares on the Form 4?

No explicit price is listed on the form; the transaction is coded as an acquisition (A) with amount 369 and price field indicated as $0 on the form.